Cyclosporine a Drives a Th17 and Th2 Mediated Post-Transplant Obliterative Airway Disease

Transplantation - United States
doi 10.1097/00007890-201211271-00256
Full Text
Abstract

Available in full text

Categories
Transplantation
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Viruses and Bacteria in Th2-Biased Allergic Airway Disease

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Activation of Eosinophil CCR3 Signaling and Eotaxin Using a Bioinformatics Analysis of a Mouse Model of Obliterative Airway Disease

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2014English

CD8+ IL-17 Responses and Obliterative Airway Disease Persist in T-Bet-/- Mouse Recipients of Lung Transplant Treated With Low Dose Azithromycin Therapy

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Cyclosporine Alone vs Cyclosporine Plus Methotrexate for Post-Transplant Immunosuppression After HLA-identical Sibling Bone Marrow Transplantation: A Randomized Prospective Study

Bone Marrow Transplantation
TransplantationHematology
2004English

Post-Transplant Lymphoproliferative Disease – PTLD

2012English

Double Deficiency for ROR T and T-Bet Drives Th2-Mediated Allograft Rejection in Mice

Journal of Immunology
AllergyImmunology
2013English

Tissue Inhibitor of Metalloproteinase-1 Deficiency Abrogates Obliterative Airway Disease After Heterotopic Tracheal Transplantation

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2006English

Inducible Costimulator Expression Regulates the Magnitude of Th2-Mediated Airway Inflammation by Regulating the Number of Th2 Cells

PLoS ONE
Multidisciplinary
2009English

Management of Post-Transplant Hyperparathyroidism and Bone Disease

Drugs
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy